Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma

Author:

Tai Cheng-Jeng,Huang Ming-Te,Wu Chih-Hsiung,Wang Chien-Kai,Tai Chen-Jei,Chang Chun-Chao,Hsieh Cheng-I.,Chang Yu-Jia,Wu Chang-Jer,Kuo Li-Jen,Wei Po-Lei,Chen Ray-Jade,Chiou Hung-Yi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference22 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study;Bramhall;Br J Surg,1995

3. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?;Nitecki;Ann Surg,1995

4. Prognostic indicators for survival after resection of pancreatic adenocarcinoma;Geer;Am J Surg,1993

5. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the “2011 ASCO Gastrointestinal Cancers Symposium.’ San Francisco, CA, USA. January 20–22, 2011;Chang;JOP,2011

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3